Exosomes of human placenta-derived mesenchymal stem cells stimulate angiogenesis

Stem Cell Res Ther. 2017 Oct 3;8(1):219. doi: 10.1186/s13287-017-0660-9.

Abstract

Background: The therapeutic potential of mesenchymal stem cells (MSCs) may be attributed partly to humoral factors such as growth factors, cytokines, and chemokines. Human term placental tissue-derived MSCs (PlaMSCs), or conditioned medium left over from cultures of these cells, have been reported to enhance angiogenesis. Recently, the exosome, which can transport a diverse suite of macromolecules, has gained attention as a novel intercellular communication tool. However, the potential role of the exosome in PlaMSC therapeutic action is not well understood. The purpose of this study was to evaluate PlaMSC-derived exosome angiogenesis promotion in vitro and in vivo.

Methods: MSCs were isolated from human term placental tissue by enzymatic digestion. Conditioned medium was collected after 48-h incubation in serum-free medium (PlaMSC-CM). Angiogenic factors present in PlaMSC-CM were screened by a growth factor array. Exosomes were prepared by ultracentrifugation of PlaMSC-CM, and confirmed by transmission electron microscopy, dynamic light scattering, and western blot analyses. The proangiogenic activity of PlaMSC-derived exosomes (PlaMSC-exo) was assessed using an endothelial tube formation assay, a cell migration assay, and reverse transcription-PCR analysis. The in-vivo angiogenic activity of PlaMSC-exo was evaluated using a murine auricle ischemic injury model.

Results: PlaMSC-CM contained both angiogenic and angiostatic factors, which enhanced endothelial tube formation. PlaMSC-exo were incorporated into endothelial cells; these exosomes stimulated both endothelial tube formation and migration, and enhanced angiogenesis-related gene expression. Laser Doppler blood flow analysis showed that PlaMSC-exo infusion also enhanced angiogenesis in an in-vivo murine auricle ischemic injury model.

Conclusions: PlaMSC-exo enhanced angiogenesis in vitro and in vivo, suggesting that exosomes play a role in the proangiogenic activity of PlaMSCs. PlaMSC-exo may be a novel therapeutic approach for treating ischemic diseases.

Keywords: Angiogenesis; Conditioned medium; Exosomes; Mesenchymal stem cells; Placenta.

MeSH terms

  • Angiogenic Proteins / isolation & purification
  • Angiogenic Proteins / pharmacology*
  • Animals
  • Biological Assay
  • Cell Movement
  • Culture Media, Conditioned / chemistry
  • Culture Media, Serum-Free
  • Ear Auricle / blood supply
  • Ear Auricle / drug effects*
  • Ear Auricle / injuries
  • Ear Auricle / pathology
  • Exosomes / chemistry
  • Exosomes / transplantation*
  • Female
  • Humans
  • Intercellular Signaling Peptides and Proteins / pharmacology
  • Male
  • Mesenchymal Stem Cells / chemistry
  • Mesenchymal Stem Cells / cytology
  • Mesenchymal Stem Cells / drug effects
  • Mesenchymal Stem Cells / metabolism
  • Mice
  • Mice, Nude
  • Neovascularization, Physiologic / drug effects*
  • Placenta / cytology*
  • Placenta / metabolism
  • Pregnancy
  • Primary Cell Culture
  • Reperfusion Injury / metabolism
  • Reperfusion Injury / pathology
  • Reperfusion Injury / therapy*

Substances

  • Angiogenic Proteins
  • Culture Media, Conditioned
  • Culture Media, Serum-Free
  • Intercellular Signaling Peptides and Proteins